Clinical Trial Update: A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the immune response and safety of an investigational chickenpox vaccine co-administered with a marketed measles, mumps …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chickenpox

Drugs mentioned

• Investigational varicella (chickenpox) vaccine
• Measles, Mumps, and Rubella vaccine (Measles, Mumps, and Rubella vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Chickenpox | Phase 3 | Status: RECRUITING